Home › Funds › Royal Palms Capital LLC › TEVA

Royal Palms Capital LLC position in TEVA

TEVA PHARMACEUTICAL IND LTD · Health Care

Royal Palms Capital LLC reported holding 82,550 shares of TEVA (TEVA PHARMACEUTICAL IND LTD) in its Q2 2026 13F filing — a position valued at US$2.8M, representing 2.46% of its reported portfolio and ranking #21 among its reported holdings. Royal Palms Capital LLC has disclosed TEVA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)82.55K sh
Reported value held$2.80M
Portfolio Weight2.46%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

How Royal Palms Capital LLC's TEVA position evolved

Royal Palms Capital LLC first disclosed a stake in TEVA in Q4 2025 at 113,857 shares (US$3.6M). Across 3 filings, Royal Palms Capital LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 82,550 shares valued at US$2.8M — a reduction of -6,240 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 113.86K $3.55M New
Q1 2026 88.79K $2.67M Reduce
Q2 2026 82.55K $2.80M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL IND LTD) is a Health Care company. 43 other funds we track also report a position in TEVA — the largest reported positions include Harel Insurance Investments & Financial Services Ltd. (US$1.63B), Phoenix Financial Ltd. (US$1.45B), WCM INVESTMENT MANAGEMENT, LLC (US$1.38B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →